FA
GWPH

Forefront Analytics’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Forefront Analytics’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20
Closed -$1.75K – 144
2020
Q1 		$1.75K Buy
+20
New +$2.12K ﹤0.01% 108

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Forefront Analytics's GWPH Position: Q2 2020 in Review

Forefront Analytics sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 20 shares — an estimated $1.75K sold.

Forefront Analytics first reported a position in GWPH in Q1 2020 and held it in 1 quarter. The position peaked at $1.75K in Q1 2020. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

  • Forefront Analytics reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • Forefront Analytics sold 20 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $1.75K.
  • Forefront Analytics first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 1 quarter.
  • Forefront Analytics's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.75K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Forefront Analytics's 13F filing for Q2 2020, filed 10 Aug 2020.